To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Insulin resistance in bariatric surgery
Örebro University, School of Medical Sciences. Örebro University Hospital. Department of Surgery, Region Örebro County, Örebro, Sweden.ORCID iD: 0000-0003-4958-1611
Department of Clinical Science, Danderyds Hospital, Karolinska Institutet; Department of Surgery, Ersta hospital, Stockholm, Sweden.
2020 (English)In: Current opinion in clinical nutrition and metabolic care, ISSN 1363-1950, E-ISSN 1473-6519, Vol. 23, no 4, p. 255-261Article, review/survey (Refereed) Published
Abstract [en]

PURPOSE OF REVIEW: To give an updated review on the underlying mechanisms and clinical effects of improved glucose control after bariatric surgery.

RECENT FINDINGS: The basic principles of the mechanism for the metabolic effects of bariatric surgery can be categorized into calorie restriction, deviation of nutrients, and reduced amounts of adipose tissue. Recent findings suggest the importance of early changes following deviation of nutrients to more distal parts of the small bowel resulting in altered release of gastrointestinal hormones, altered gut microbiota, and weight-reduction. In the long-term, loss of adipose tissue results in reduced inflammation and improved insulin sensitivity. From a clinical perspective these changes are associated with remission of diabetes in patients with morbid obesity and type 2 diabetes, prevention of diabetes in patients with insulin resistance without overt type 2 diabetes and prevention of both microvascular and macrovascular complications for all patients with morbid obesity.

SUMMARY: At present, bariatric surgery remains the most effective treatment option to improve glucose control and long-term complications associated with hyperglycemia in patients with obesity.Although the mechanisms behind these metabolic effects remain only partially understood, further knowledge on these complex mechanisms may help identifying durable treatment options for morbid obesity and important metabolic comorbidities.

Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2020. Vol. 23, no 4, p. 255-261
Keywords [en]
bariatric surgery, insulin resistance, metabolic syndrome, obesity
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-82682DOI: 10.1097/MCO.0000000000000657ISI: 000546337500006PubMedID: 32205577Scopus ID: 2-s2.0-85086051163OAI: oai:DiVA.org:oru-82682DiVA, id: diva2:1436566
Note

Funding Agencies:

Bengt Ihre Foundation  

Region Örebro County  

Erling-Persson Family Foundation  

Available from: 2020-06-08 Created: 2020-06-08 Last updated: 2020-12-01Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Stenberg, Erik

Search in DiVA

By author/editor
Stenberg, Erik
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
Current opinion in clinical nutrition and metabolic care
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 116 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf